X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (506) 506
Publication (33) 33
Book Review (17) 17
Book Chapter (6) 6
Conference Proceeding (2) 2
Book / eBook (1) 1
Magazine Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
golimumab (495) 495
index medicus (263) 263
humans (226) 226
infliximab (204) 204
adalimumab (194) 194
rheumatoid arthritis (157) 157
rheumatology (140) 140
antibodies, monoclonal - therapeutic use (129) 129
double-blind (122) 122
ulcerative colitis (115) 115
female (113) 113
etanercept (111) 111
male (111) 111
adult (99) 99
treatment outcome (94) 94
tumor necrosis factor-alpha - antagonists & inhibitors (93) 93
middle aged (92) 92
efficacy (86) 86
safety (86) 86
pharmacology & pharmacy (81) 81
antirheumatic agents - therapeutic use (78) 78
methotrexate (77) 77
arthritis, rheumatoid - drug therapy (76) 76
psoriatic arthritis (73) 73
arthritis (71) 71
necrosis-factor-alpha (70) 70
therapy (70) 70
certolizumab (64) 64
ankylosing spondylitis (60) 60
rheumatoid-arthritis (59) 59
antibodies, monoclonal - adverse effects (54) 54
inflammatory bowel disease (54) 54
certolizumab pegol (52) 52
antibodies, monoclonal - administration & dosage (48) 48
aged (46) 46
arthritis, psoriatic - drug therapy (45) 45
gastroenterology & hepatology (44) 44
phase-iii (44) 44
medicine & public health (43) 43
psoriasis (42) 42
inflammatory-bowel-disease (41) 41
severity of illness index (41) 41
tocilizumab (40) 40
tumor necrosis factor (39) 39
vedolizumab (39) 39
ankylosing-spondylitis (38) 38
clinical-response (37) 37
remission (37) 37
abatacept (36) 36
biologics (36) 36
monoclonal antibodies (36) 36
monoclonal-antibody (36) 36
tumor necrosis factor-tnf (36) 36
clinical trials (34) 34
crohn's disease (34) 34
crohns-disease (34) 34
patients (34) 34
drug therapy, combination (33) 33
multicenter (33) 33
every 4 weeks (32) 32
spondylitis, ankylosing - drug therapy (32) 32
maintenance therapy (31) 31
tnf inhibitors (31) 31
active rheumatoid-arthritis (30) 30
anti-tnf (30) 30
antibodies, monoclonal - pharmacokinetics (30) 30
colitis, ulcerative - drug therapy (30) 30
drug therapy (30) 30
inflammation (29) 29
pharmacokinetics (29) 29
rheumatoid factor (29) 29
tumor-necrosis-factor (29) 29
young adult (29) 29
analysis (28) 28
antirheumatic agents - administration & dosage (28) 28
internal medicine (28) 28
methotrexate - therapeutic use (28) 28
remission induction (28) 28
rituximab (28) 28
animals (27) 27
disease-activity (27) 27
double-blind method (27) 27
methotrexate therapy (27) 27
placebo-controlled trial (27) 27
immunology (26) 26
time factors (26) 26
ustekinumab (26) 26
care and treatment (25) 25
antibodies, monoclonal, humanized - therapeutic use (24) 24
disease progression (24) 24
studies (24) 24
tumor necrosis factor-alpha - immunology (24) 24
antibodies, monoclonal - pharmacology (23) 23
review (23) 23
antirheumatic agents - adverse effects (22) 22
anti-inflammatory agents - therapeutic use (21) 21
injections, subcutaneous (21) 21
medicine, general & internal (21) 21
uveitis (21) 21
anti-tnf therapy (20) 20
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (445) 445
Russian (15) 15
German (13) 13
Korean (10) 10
Spanish (9) 9
French (7) 7
Slovak (6) 6
Czech (3) 3
Japanese (3) 3
Hungarian (1) 1
Polish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Modern Rheumatology, ISSN 1439-7595, 07/2018, Volume 28, Issue 4, pp. 712 - 715
Journal Article
Clinical and Experimental Rheumatology, ISSN 0392-856X, 01/2018, Volume 36, Issue 1, pp. 140 - 143
Objective. Clinical data suggest that the response of rheumatoid arthritis patients to treatment with golimumab is much lower among those who switched from... 
Golimumab | Treatment | Cytokines | Adalimumab | Rheumatoid arthritis | treatment | cytokines | RHEUMATOLOGY | rheumatoid arthritis | adalimumab | golimumab
Journal Article
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, ISSN 0392-856X, 03/2019, Volume 37, Issue 2, pp. 301 - 305
Objective. To assess the efficacy of monoclonal anti-tumour necrosis factor (TNF)-alpha agents in patients with anterior uveitis (AU) in terms of decrease of... 
anterior uveitis | MULTICENTER | infliximab | certolizumab | RHEUMATOLOGY | adalimumab | golimumab
Journal Article
ARTHRITIS RESEARCH & THERAPY, ISSN 1478-6354, 08/2019, Volume 21, Issue 1, pp. 190 - 9
Journal Article
JOURNAL OF RHEUMATOLOGY, ISSN 0315-162X, 10/2019, Volume 46, Issue 10, pp. 1277 - 1283
Objective. Evaluate safety and efficacy of intravenous (IV) golimumab (GOL) in patients with active ankylosing spondylitis (AS) through 1 year. Methods. A... 
RECOMMENDATIONS | GOLIMUMAB | PREFERENCES | ANTI-TUMOR NECROSIS FACTOR THERAPY | IMPROVEMENT | ANKYLOSING SPONDYLITIS | RHEUMATOLOGY | BIOLOGICS | BATH | INTRAVENOUS
Journal Article
Scandinavian Journal of Gastroenterology, ISSN 0036-5521, 06/2019, Volume 54, Issue 6, pp. 700 - 706
Background: Golimumab (GLM) is approved for the treatment of moderate to severe ulcerative colitis (UC). Higher serum concentrations of anti-tumor necrosis... 
Inflammatory bowel disease | pharmacokinetics | ulcerative colitis | concentration-effect relationship | golimumab | Index Medicus
Journal Article
ARTHRITIS & RHEUMATOLOGY, ISSN 2326-5191, 04/2014, Volume 66, Issue 4, pp. 794 - 802
Objective. To develop and validate composite disease activity scores, based on widely available clinical measures, that would demonstrate improved correlation... 
GO-FORWARD | GOLIMUMAB | PHASE-III | DOUBLE-BLIND | ANTIBODY | NECROSIS-FACTOR-ALPHA | RHEUMATOLOGY | ACTIVITY INDEX | CLINICAL-PRACTICE | VALIDITY | METHOTREXATE THERAPY
Journal Article
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, ISSN 0392-856X, 05/2019, Volume 37, Issue 3, pp. 367 - 372
Objective To investigate ex-vivo drug-inhibited cytokine production before the start of a biological DMARD (bDMARD) as predictor of treatment response in... 
CELLS | ADALIMUMAB | bDMARD | biomarkers | GOLIMUMAB | prediction of response | cytokines | RHEUMATOLOGY | rheumatoid arthritis | DISEASE-ACTIVITY
Journal Article
Clinical Rheumatology, ISSN 0770-3198, 6/2015, Volume 34, Issue 6, pp. 1141 - 1143
We report on a patient with a long-standing history of recurrent oral aphthosis and pseudofolliculitis, diagnosed with Behçet’s disease (BD), previously... 
Golimumab | Medicine & Public Health | Oral aphthosis | Tocilizumab | Rheumatology | Genital ulcers | Behçet’s disease (BD)
Journal Article
Revue du rhumatisme, ISSN 1169-8330, 12/2015, Volume 82, Issue 6, pp. 424 - 425
Journal Article
Clinical Rheumatology, ISSN 0770-3198, 9/2017, Volume 36, Issue 9, pp. 2063 - 2069
Our aim was to retrospectively assess the role of golimumab as a treatment choice in patients with Behçet’s disease (BD). Seventeen patients diagnosed with BD... 
Golimumab | Disease activity | Medicine & Public Health | Autoinflammatory disease | TNF-α | Biologics | Rheumatology | Behçet’s disease
Journal Article
Seminars in Arthritis and Rheumatism, ISSN 0049-0172, 2017, Volume 47, Issue 1, pp. 108 - 114
Journal Article
Survey of Ophthalmology, ISSN 0039-6257, 2015, Volume 60, Issue 6, pp. 575 - 589
Since the first reported use in 2001 of an anti-tumor necrosis factor-alpha (TNF-α) agent, infliximab, for the treatment of uveitis, several new anti-TNF-α... 
Golimumab | Therapy | Tumor necrosis factor-alpha | Etanercept | Infliximab | Certolizumab | Pharmacogenomics of anti-TNF-α | Uveitis | Adalimumab | Anti-drug antibodies | Serum levels of anti-TNF-α drug
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.